Parliamentary Inquiry into allergic diseases
12 September 2019:
In the ASCIA 2019 Conference opening address by the Minister for Health, the Hon Greg Hunt MP announced that a parliamentary inquiry into allergic diseases will be undertaken by the Standing Committee on Health. This will provide an opportunity for a thorough investigation into issues regarding the management of allergic diseases in Australia. For details go to Allergies and anaphylaxis under the microscope.
The ASCIA submission will focus on issues that are consistent with the following Terms of Reference that the House of Representatives Standing Committee on Health, Aged Care and Sport will inquire into and report on:
- The potential and known causes, prevalence, impacts and costs of anaphylaxis in Australia;
- The adequacy of food and drug safety process and food and drug allergy management, auditing and compliance (including food allergen labelling by manufacturers and food service providers);
- The adequacy and consistency of professional education, training, management/treatment standards and patient record systems for allergy and anaphylaxis;
- Access to and cost of services, including diagnosis, testing, management, treatment and support;
- Developments in research into allergy and anaphylaxis including prevention, causes, treatment and emerging treatments (such as oral immunotherapy);
- Unscientific diagnosis and treatments being recommended and used by some consumers; and
- The impact of unnecessary drug avoidance due to unconfirmed drug allergies and its management, such drug allergy ‘de-labelling’.
For details about how individuals can lodge a submission go to the Standing Committee on Health’s website